1. Home
  2. BFST vs WVE Comparison

BFST vs WVE Comparison

Compare BFST & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFST
  • WVE
  • Stock Information
  • Founded
  • BFST 2006
  • WVE 2012
  • Country
  • BFST United States
  • WVE Singapore
  • Employees
  • BFST N/A
  • WVE N/A
  • Industry
  • BFST Major Banks
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • BFST Finance
  • WVE Health Care
  • Exchange
  • BFST Nasdaq
  • WVE Nasdaq
  • Market Cap
  • BFST 783.9M
  • WVE 915.6M
  • IPO Year
  • BFST 2018
  • WVE 2015
  • Fundamental
  • Price
  • BFST $23.78
  • WVE $9.76
  • Analyst Decision
  • BFST Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • BFST 3
  • WVE 16
  • Target Price
  • BFST $30.00
  • WVE $20.00
  • AVG Volume (30 Days)
  • BFST 95.2K
  • WVE 1.6M
  • Earning Date
  • BFST 07-28-2025
  • WVE 07-30-2025
  • Dividend Yield
  • BFST 2.35%
  • WVE N/A
  • EPS Growth
  • BFST 3.92
  • WVE N/A
  • EPS
  • BFST 2.51
  • WVE N/A
  • Revenue
  • BFST $291,096,000.00
  • WVE $93,946,000.00
  • Revenue This Year
  • BFST $25.48
  • WVE N/A
  • Revenue Next Year
  • BFST $17.20
  • WVE $4.55
  • P/E Ratio
  • BFST $9.46
  • WVE N/A
  • Revenue Growth
  • BFST 17.48
  • WVE N/A
  • 52 Week Low
  • BFST $20.07
  • WVE $5.04
  • 52 Week High
  • BFST $30.30
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • BFST 44.72
  • WVE 72.03
  • Support Level
  • BFST $22.62
  • WVE $8.40
  • Resistance Level
  • BFST $24.71
  • WVE $9.03
  • Average True Range (ATR)
  • BFST 0.61
  • WVE 0.55
  • MACD
  • BFST 0.04
  • WVE 0.06
  • Stochastic Oscillator
  • BFST 46.40
  • WVE 98.53

About BFST Business First Bancshares Inc.

Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: